AU1155399A - Use of clonidine for treatment of addictions, epilepsy, sleep disorders, eating disorders and migraines - Google Patents

Use of clonidine for treatment of addictions, epilepsy, sleep disorders, eating disorders and migraines

Info

Publication number
AU1155399A
AU1155399A AU11553/99A AU1155399A AU1155399A AU 1155399 A AU1155399 A AU 1155399A AU 11553/99 A AU11553/99 A AU 11553/99A AU 1155399 A AU1155399 A AU 1155399A AU 1155399 A AU1155399 A AU 1155399A
Authority
AU
Australia
Prior art keywords
disorders
addictions
migraines
clonidine
epilepsy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11553/99A
Inventor
Arthur Janov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU1155399A publication Critical patent/AU1155399A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU11553/99A 1998-06-11 1998-10-05 Use of clonidine for treatment of addictions, epilepsy, sleep disorders, eating disorders and migraines Abandoned AU1155399A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9629498A 1998-06-11 1998-06-11
US09096294 1998-06-11
PCT/EP1998/006656 WO1999063997A1 (en) 1998-06-11 1998-10-05 Use of clonidine for treatment of addictions, epilepsy, sleep disorders, eating disorders and migraines

Publications (1)

Publication Number Publication Date
AU1155399A true AU1155399A (en) 1999-12-30

Family

ID=22256703

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11553/99A Abandoned AU1155399A (en) 1998-06-11 1998-10-05 Use of clonidine for treatment of addictions, epilepsy, sleep disorders, eating disorders and migraines

Country Status (2)

Country Link
AU (1) AU1155399A (en)
WO (1) WO1999063997A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2624577T3 (en) 2006-02-13 2017-07-17 Orient Pharma (Samoa) Co. Ltd. Liquid formulation comprising an agonist of the alpha-2 receptors (eg, clonidine) and oxybutynin (antimuscarinic agent) for the treatment of sialorrhea
US20100196286A1 (en) * 2008-12-01 2010-08-05 Armer Thomas A Inhalation delivery methods and devices
US8515882B2 (en) 2010-11-18 2013-08-20 International Business Machines Corporation Efficient storage of individuals for optimization simulation
US8489526B2 (en) 2010-11-24 2013-07-16 International Business Machines Corporation Controlling quarantining and biasing in cataclysms for optimization simulations
US9563844B2 (en) 2011-06-30 2017-02-07 International Business Machines Corporation Speculative asynchronous sub-population evolutionary computing utilizing a termination speculation threshold
US9165247B2 (en) 2012-01-04 2015-10-20 International Business Machines Corporation Using global and local catastrophes across sub-populations in parallel evolutionary computing
US9305257B2 (en) 2013-05-20 2016-04-05 International Business Machines Corporation Adaptive cataclysms in genetic algorithms
US8987327B1 (en) 2013-10-11 2015-03-24 Eugene Lipov Kits and methods for treating post traumatic stress disorder (PTSD) and hot flashes

Also Published As

Publication number Publication date
WO1999063997A1 (en) 1999-12-16

Similar Documents

Publication Publication Date Title
AU2002255248A1 (en) Diagnosis, treatment and research of mental disorders
AU2001279707A1 (en) Diagnosis of behavioural disorders, neurological disorders and cancer
IL160524A0 (en) Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
HUP9900163A2 (en) Process for the preparation of sterol-and stanol-esters, and use thereof
AU7526798A (en) Acetamide and urea derivatives, process for their preparation and their use in the treatment of cns disorders
HK1026141A1 (en) Treatment of sleep apnea.
WO2002086502A8 (en) Methods for the diagnosis and treatment of bone disorders
ZA989667B (en) The use of MMP-13 selective inhibitors for the treatment of osteoarthritis and other MMP-mediated disorders.
ZA200306171B (en) (Diazolo-pyridinyl)-pyrimidines for use in treatment of CNS disorders and diabetes.
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
AU6910600A (en) Methods for the treatment of mental disorders
ZA200402514B (en) 4[Piperidin-4-yliden-(3-carbamoylphenyl)methyl]benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders.
AU2001271887A1 (en) Methods for diagnosis and treatment of psychiatric disorders
EP1126850A4 (en) Treatment of disorders of the outer retina
PL369850A1 (en) Substituted indoles, method for production and use thereof for the inhibition of pain
MXPA03004303A (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain.
AU2002220735A1 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
AU1155399A (en) Use of clonidine for treatment of addictions, epilepsy, sleep disorders, eating disorders and migraines
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
AU3593599A (en) Drugs for reducing vaginal acidity and treatment of vaginitis, and the use thereof
GB0128674D0 (en) Treatment of sleep disorders and the like
AU7106300A (en) Treatment of skin disorders
AU2001251306A1 (en) Treatment of sleep disorders with hypocretin-1
AU7595298A (en) Azolidinediones useful for the treatment of diabetes, dyslipidemia and hy pertension
AU2003232699A1 (en) System and device for massage, pressure-treatment and heat-treatment of skin and parts of the body

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase